The extreme EPS miss (-4275%) signals severe dilution or non-cash charges that may spook momentum traders despite the revenue growth. Monitor the 10-Q for share count and one-time items; the equity improvement is a positive but unlikely to offset EPS shock in the near term.
Price Chart
Executive Summary
Healthcare Triangle reported Q2 2026 revenue of $9.19M (+158% YoY) and gross profit of $2.07M (+322% YoY), driven by the Teyame/Datono acquisition which contributed 69% of revenue. However, EPS of -$150.07 was a massive miss vs consensus of -$3.43, reflecting significant dilution or one-time items. Stockholders' equity improved to $49.1M from $9.9M, but the extreme EPS miss overshadows the revenue growth for traders focused on earnings quality.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $9.19M, +158% YoY from $3.56M
- Gross profit $2.07M, +322% YoY; gross margin 22.5% vs 13.8%
- EPS -$150.07 vs consensus -$3.43 (-4275% miss)
- AI-powered customer engagement segment contributed $6.31M revenue (69% of total)
- Stockholders' equity rose to $49.1M from $9.9M at Dec 2025
Financial Impact
EPS miss of -$146.64 vs consensus; revenue beat of -$1.11M vs $10.3M estimate (actual $9.19M)
Risk Factors
- EPS miss of -4275% may trigger sell-off regardless of revenue growth
- Acquisition integration costs or dilution from Teyame/Datono deal could pressure future EPS
- Low market cap ($19M) amplifies volatility on any news
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302850835 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | DEF 14A | $0.3820 | awaiting T+20 | — | — |
Oct 2, 2026 23d ago | 8-K | $0.6069 | awaiting T+20 | — | — |
Oct 1, 2026 25d ago | EFFECT | $0.7016 | awaiting T+20 | — | — |
Aug 13, 2026 10w ago | Press Release | $1.73 $0.7457 | ▲ +56.90% | ▲ +55.15% | — |
Jul 29, 2026 12w ago | 8-K | $1.56 $0.8683 | ▲ +44.34% | ▲ +49.36% | — |
Jul 27, 2026 13w ago | Press Release | $1.70 $0.8446 | ▼ −50.32% | ▼ −53.62% | — |
Jul 16, 2026 14w ago | EFFECT | $1.89 $1.73 | ▲ +8.47% | ▲ +12.08% | — |
Jun 26, 2026 17w ago | 8-K | $1.88 $1.62 | ▲ +13.83% | ▲ +13.55% | — |
Jun 15, 2026 18w ago | 8-K | $2.30 $1.74 | ▲ +24.35% | ▲ +24.55% | — |
Apr 16, 2026 27w ago | 10-K/A | $2.47 $2.28 | ▲ +7.69% | ▲ +13.06% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers